{"id":1459,"date":"2022-12-05T13:27:54","date_gmt":"2022-12-05T18:27:54","guid":{"rendered":"https:\/\/research.ncsu.edu\/win\/?p=1459"},"modified":"2023-11-09T14:49:51","modified_gmt":"2023-11-09T19:49:51","slug":"deep-blue-medical-advances-announces-fda-clearance","status":"publish","type":"post","link":"https:\/\/research.ncsu.edu\/win\/deep-blue-medical-advances-announces-fda-clearance\/","title":{"rendered":"Deep Blue Medical Advances Announces FDA Clearance for Sublay Application in Hernia Surgery, Enabling Broader Use of T-Line Hernia Mesh"},"content":{"rendered":"
Read Full Article <\/span>\n\t\t<\/use>\n<\/svg>\n<\/span><\/a><\/div>\n\n<\/div>\n\n\n\n

DURHAM, N.C.<\/span><\/span>,\u00a0<\/span>Dec. 5, 2022<\/span><\/span>\u00a0\/PRNewswire\/ — Deep Blue Medical Advances announced today it has received an additional 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its T-Line\u00ae\u00a0Hernia Mesh for the sublay technique in open hernia surgery. This significantly expands the patient population that can be treated with T-Line and experience the unique benefits of its novel design and application.<\/span><\/p>\n

\n
\n
\n
\n
\n
\n
\n
\n